lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro

Two human pancreatic cell lines, MIA PaCa 2 and Capan 2, were treated by photodynamic therapy in vitro with Photophrin (0.01-25 micrograms/ml; 24 h) and then light (1-50 J/cm2; lambda = 630 nm). The following model was fit to 6 datasets with weighted nonlinear regression: [sequence: see text] The sy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 1995-07, Vol.55 (14), p.3078-3084
Hauptverfasser: MOESTA, K. T, GRECO, W. R, NURSE-FINLAY, S. O, PARSONS, J. C, MANG, T. S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3084
container_issue 14
container_start_page 3078
container_title Cancer research (Chicago, Ill.)
container_volume 55
creator MOESTA, K. T
GRECO, W. R
NURSE-FINLAY, S. O
PARSONS, J. C
MANG, T. S
description Two human pancreatic cell lines, MIA PaCa 2 and Capan 2, were treated by photodynamic therapy in vitro with Photophrin (0.01-25 micrograms/ml; 24 h) and then light (1-50 J/cm2; lambda = 630 nm). The following model was fit to 6 datasets with weighted nonlinear regression: [sequence: see text] The symbols are: E, cell growth; Econ, control growth in the absence of the combination; B, background signal; m, slope parameter; gamma, interaction parameter; D, concentration of Photofrin; L, light dose; F, fraction of Photofrin not photobleached by the light dose; k, k1, k2, bleaching parameters; A, distribution parameter for biexponential bleaching equation. Simple reciprocity of photosensitizer concentration and light dose was not found; compensation for photobleaching was critical. MIA PaCa2 required the monoexponential bleaching factor, whereas Capan 2 required the biexponential bleaching factor. The greater photosensitivity of MIA PaCa2 over Capan 2 can be best explained not by differences in the interaction parameter but rather by differences in the photobleaching pattern and rate. It may be possible to further enhance the selectivity of photodynamic therapy if differences in photobleaching between different cell types can be exploited by adequate dosimetry.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_77382245</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77382245</sourcerecordid><originalsourceid>FETCH-LOGICAL-h269t-b76b33b543db7b8d098bbf477d57e60da17ea6dc2c3011dd3262ef50c50218b93</originalsourceid><addsrcrecordid>eNo9kEtLxDAUhYso4zj6E4QsxF0hTZqks5TBFwhudF1uHp2JtklNUqH_3owWV5d7zncPnHtSrCtGm1LUNTst1hjjpmS1IOfFRYwfeWUVZqtiJTjmguJ1EXtQn8h3KBhlx-CVTTOyDukw7RE4jXq7PySkfTRIm9E4bZwyx4Px4JPXs4PBKpQOJsA4_-rgVDCQsgoZ9gqCss4PcIz9tin4y-Ksgz6aq2VuiveH-7fdU_ny-vi8u3spD4RvUykFl5RKVlMthWw03jZSdrUQmgnDsYZKGOBaEUVxVWlNCSemY1gxTKpGbummuP3Lzb2-JhNTO9ioTN-DM36KrRC0IaRmGbxewEkORrdjsAOEuV2-lP2bxYeooO9CrmjjP0Z5lXMI_QF0q3Ln</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77382245</pqid></control><display><type>article</type><title>lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><creator>MOESTA, K. T ; GRECO, W. R ; NURSE-FINLAY, S. O ; PARSONS, J. C ; MANG, T. S</creator><creatorcontrib>MOESTA, K. T ; GRECO, W. R ; NURSE-FINLAY, S. O ; PARSONS, J. C ; MANG, T. S</creatorcontrib><description>Two human pancreatic cell lines, MIA PaCa 2 and Capan 2, were treated by photodynamic therapy in vitro with Photophrin (0.01-25 micrograms/ml; 24 h) and then light (1-50 J/cm2; lambda = 630 nm). The following model was fit to 6 datasets with weighted nonlinear regression: [sequence: see text] The symbols are: E, cell growth; Econ, control growth in the absence of the combination; B, background signal; m, slope parameter; gamma, interaction parameter; D, concentration of Photofrin; L, light dose; F, fraction of Photofrin not photobleached by the light dose; k, k1, k2, bleaching parameters; A, distribution parameter for biexponential bleaching equation. Simple reciprocity of photosensitizer concentration and light dose was not found; compensation for photobleaching was critical. MIA PaCa2 required the monoexponential bleaching factor, whereas Capan 2 required the biexponential bleaching factor. The greater photosensitivity of MIA PaCa2 over Capan 2 can be best explained not by differences in the interaction parameter but rather by differences in the photobleaching pattern and rate. It may be possible to further enhance the selectivity of photodynamic therapy if differences in photobleaching between different cell types can be exploited by adequate dosimetry.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 7606730</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adenocarcinoma - drug therapy ; Adenocarcinoma - metabolism ; Biological and medical sciences ; Computer Simulation ; Dose-Response Relationship, Drug ; Hematoporphyrin Derivative - pharmacokinetics ; Hematoporphyrin Derivative - pharmacology ; Humans ; Medical sciences ; Models, Biological ; Pancreatic Neoplasms - drug therapy ; Pancreatic Neoplasms - metabolism ; Photochemotherapy - methods ; Photoradiation therapy and photosensitizing agent ; Thymidine - metabolism ; Treatment with physical agents ; Treatment. General aspects ; Tritium ; Tumor Cells, Cultured - drug effects ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 1995-07, Vol.55 (14), p.3078-3084</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3618222$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7606730$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MOESTA, K. T</creatorcontrib><creatorcontrib>GRECO, W. R</creatorcontrib><creatorcontrib>NURSE-FINLAY, S. O</creatorcontrib><creatorcontrib>PARSONS, J. C</creatorcontrib><creatorcontrib>MANG, T. S</creatorcontrib><title>lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Two human pancreatic cell lines, MIA PaCa 2 and Capan 2, were treated by photodynamic therapy in vitro with Photophrin (0.01-25 micrograms/ml; 24 h) and then light (1-50 J/cm2; lambda = 630 nm). The following model was fit to 6 datasets with weighted nonlinear regression: [sequence: see text] The symbols are: E, cell growth; Econ, control growth in the absence of the combination; B, background signal; m, slope parameter; gamma, interaction parameter; D, concentration of Photofrin; L, light dose; F, fraction of Photofrin not photobleached by the light dose; k, k1, k2, bleaching parameters; A, distribution parameter for biexponential bleaching equation. Simple reciprocity of photosensitizer concentration and light dose was not found; compensation for photobleaching was critical. MIA PaCa2 required the monoexponential bleaching factor, whereas Capan 2 required the biexponential bleaching factor. The greater photosensitivity of MIA PaCa2 over Capan 2 can be best explained not by differences in the interaction parameter but rather by differences in the photobleaching pattern and rate. It may be possible to further enhance the selectivity of photodynamic therapy if differences in photobleaching between different cell types can be exploited by adequate dosimetry.</description><subject>Adenocarcinoma - drug therapy</subject><subject>Adenocarcinoma - metabolism</subject><subject>Biological and medical sciences</subject><subject>Computer Simulation</subject><subject>Dose-Response Relationship, Drug</subject><subject>Hematoporphyrin Derivative - pharmacokinetics</subject><subject>Hematoporphyrin Derivative - pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Models, Biological</subject><subject>Pancreatic Neoplasms - drug therapy</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Photochemotherapy - methods</subject><subject>Photoradiation therapy and photosensitizing agent</subject><subject>Thymidine - metabolism</subject><subject>Treatment with physical agents</subject><subject>Treatment. General aspects</subject><subject>Tritium</subject><subject>Tumor Cells, Cultured - drug effects</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLxDAUhYso4zj6E4QsxF0hTZqks5TBFwhudF1uHp2JtklNUqH_3owWV5d7zncPnHtSrCtGm1LUNTst1hjjpmS1IOfFRYwfeWUVZqtiJTjmguJ1EXtQn8h3KBhlx-CVTTOyDukw7RE4jXq7PySkfTRIm9E4bZwyx4Px4JPXs4PBKpQOJsA4_-rgVDCQsgoZ9gqCss4PcIz9tin4y-Ksgz6aq2VuiveH-7fdU_ny-vi8u3spD4RvUykFl5RKVlMthWw03jZSdrUQmgnDsYZKGOBaEUVxVWlNCSemY1gxTKpGbummuP3Lzb2-JhNTO9ioTN-DM36KrRC0IaRmGbxewEkORrdjsAOEuV2-lP2bxYeooO9CrmjjP0Z5lXMI_QF0q3Ln</recordid><startdate>19950715</startdate><enddate>19950715</enddate><creator>MOESTA, K. T</creator><creator>GRECO, W. R</creator><creator>NURSE-FINLAY, S. O</creator><creator>PARSONS, J. C</creator><creator>MANG, T. S</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19950715</creationdate><title>lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro</title><author>MOESTA, K. T ; GRECO, W. R ; NURSE-FINLAY, S. O ; PARSONS, J. C ; MANG, T. S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h269t-b76b33b543db7b8d098bbf477d57e60da17ea6dc2c3011dd3262ef50c50218b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adenocarcinoma - drug therapy</topic><topic>Adenocarcinoma - metabolism</topic><topic>Biological and medical sciences</topic><topic>Computer Simulation</topic><topic>Dose-Response Relationship, Drug</topic><topic>Hematoporphyrin Derivative - pharmacokinetics</topic><topic>Hematoporphyrin Derivative - pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Models, Biological</topic><topic>Pancreatic Neoplasms - drug therapy</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Photochemotherapy - methods</topic><topic>Photoradiation therapy and photosensitizing agent</topic><topic>Thymidine - metabolism</topic><topic>Treatment with physical agents</topic><topic>Treatment. General aspects</topic><topic>Tritium</topic><topic>Tumor Cells, Cultured - drug effects</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MOESTA, K. T</creatorcontrib><creatorcontrib>GRECO, W. R</creatorcontrib><creatorcontrib>NURSE-FINLAY, S. O</creatorcontrib><creatorcontrib>PARSONS, J. C</creatorcontrib><creatorcontrib>MANG, T. S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MOESTA, K. T</au><au>GRECO, W. R</au><au>NURSE-FINLAY, S. O</au><au>PARSONS, J. C</au><au>MANG, T. S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1995-07-15</date><risdate>1995</risdate><volume>55</volume><issue>14</issue><spage>3078</spage><epage>3084</epage><pages>3078-3084</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Two human pancreatic cell lines, MIA PaCa 2 and Capan 2, were treated by photodynamic therapy in vitro with Photophrin (0.01-25 micrograms/ml; 24 h) and then light (1-50 J/cm2; lambda = 630 nm). The following model was fit to 6 datasets with weighted nonlinear regression: [sequence: see text] The symbols are: E, cell growth; Econ, control growth in the absence of the combination; B, background signal; m, slope parameter; gamma, interaction parameter; D, concentration of Photofrin; L, light dose; F, fraction of Photofrin not photobleached by the light dose; k, k1, k2, bleaching parameters; A, distribution parameter for biexponential bleaching equation. Simple reciprocity of photosensitizer concentration and light dose was not found; compensation for photobleaching was critical. MIA PaCa2 required the monoexponential bleaching factor, whereas Capan 2 required the biexponential bleaching factor. The greater photosensitivity of MIA PaCa2 over Capan 2 can be best explained not by differences in the interaction parameter but rather by differences in the photobleaching pattern and rate. It may be possible to further enhance the selectivity of photodynamic therapy if differences in photobleaching between different cell types can be exploited by adequate dosimetry.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>7606730</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1995-07, Vol.55 (14), p.3078-3084
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_77382245
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research
subjects Adenocarcinoma - drug therapy
Adenocarcinoma - metabolism
Biological and medical sciences
Computer Simulation
Dose-Response Relationship, Drug
Hematoporphyrin Derivative - pharmacokinetics
Hematoporphyrin Derivative - pharmacology
Humans
Medical sciences
Models, Biological
Pancreatic Neoplasms - drug therapy
Pancreatic Neoplasms - metabolism
Photochemotherapy - methods
Photoradiation therapy and photosensitizing agent
Thymidine - metabolism
Treatment with physical agents
Treatment. General aspects
Tritium
Tumor Cells, Cultured - drug effects
Tumors
title lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A14%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=lack%20of%20reciprocity%20in%20drug%20and%20light%20dose%20dependence%20of%20photodynamic%20therapy%20of%20pancreatic%20adenocarcinoma%20in%20vitro&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=MOESTA,%20K.%20T&rft.date=1995-07-15&rft.volume=55&rft.issue=14&rft.spage=3078&rft.epage=3084&rft.pages=3078-3084&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E77382245%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77382245&rft_id=info:pmid/7606730&rfr_iscdi=true